USPTO serial 86660995
ONCOBEAM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 13, 2021
- Examiner
- FINK, GINA M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ONCOBEAM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical reagents, other than for medical or veterinary use; chemical preparations for testing of biological samples, other than for medical or veterinary use; biochemicals, namely, primer, probe or dNTP (deoxynucleotide triphosphate) for scientific or research use; biochemical reagents for nonmedical use; enzymes for scientific and research use; testing reagents and preparations, namely, biological sample testing reagents used for non-medical purposes; reagents for genetic test, namely, gene mutation tests comprised of reagents for non-medical purposes; diluents for diluting samples or reagents other than for medical or veterinary use; buffer solutions used for testing of biological samples other than for medical or veterinary use; surfactants for pretreatment of samples for genetic testing; reference control materials, namely, calibrating and quality control fluids or lyophilized one for testing and calibrating of apparatus or reagents for scientific or research use; chemical reference materials for scientific or research use, namely, chemical solutions and preparations for testing and calibrating of apparatus or reagents; quality control standard solutions and quality control materials used for testing and calibrating scientific or laboratory apparatus, namely, artificial DNA; emulsifying agents used for preparing emulsion for genetic testing for non-medical purposes; chemical products for forming emulsion; chemical products for breaking emulsion; magnetic beads for use in scientific or research analysis sold as a component part of nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; DNA polymerase sold as a component part of reagent kits comprising DNA primers and polymerase for use in biotechnology fields; and chemical preparations containing DNA fragments sold as component of reagent kit for use in genetic testing for non-medical purposes | ACTIVE | — |
| 003 | Detergents for cleaning apparatus and instruments for genetic testing; cleaning solutions, namely, chemical cleaning solutions for genetic testing; cleaning preparations; and cleaning preparations for apparatus and instruments | ACTIVE | — |
| 005 | Diagnostic reagents and diagnostic preparations for medical or veterinary use; chemical reagents for medical or veterinary use; chemical preparations for medical or veterinary purposes, namely, for testing of biological samples; biochemical reagents for medical use, namely, diagnostic reagents for medicinal use; enzymes for use in medical analysis; testing reagents and preparations for medical or veterinary use, namely, medical diagnostic reagents and assays for testing of fluids and tissues; reagents for genetic testing for medical or veterinary purposes; preparations for detecting mutations in genes for medical or veterinary purposes; diagnostic biomarker reagents for medical or veterinary use; clinical medical reagents for clinical cancer test; diluents for medical or veterinary use, namely, for diluting samples or reagents used in genetic testing; reference control materials for medical or veterinary use, namely, for testing and calibrating of apparatus or reagents; quality control standard solutions and quality control materials for testing and calibrating medical or veterinary apparatus, namely, artificial DNA; detergents for medical or veterinary use; cleaning solutions for medical or veterinary use, namely, for cleaning medical apparatus and instruments; cleaning preparations for medical or veterinary use, namely, for cleaning medical apparatus and instruments; sheath solutions to be used in detecting analyte using flow cytometry for medical use; magnetic beads for use in medical analysis sold as a feature of nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for medical purposes; DNA polymerase for use in medical analysis, namely, enzymes for medical diagnostic purposes and chemical preparations containing DNA fragments for use in medical analysis, namely, chemical preparations for medical purposes, namely, for genetic testing | ACTIVE | — |
| 009 | Testing apparatus and instruments, namely, flow cytometers, thermal cyclers, liquid handlers, sequencers and centrifuges for scientific, research or laboratory use; laboratory apparatus and instruments, namely, flow cytometers, thermal cyclers, liquid handlers, sequencers and centrifuges; laboratory furniture for use in genetic testing; flow cytometers providing cell and particle analysis, detection, or counting for scientific or laboratory use; flow-based particle analyzers providing cell and particle analysis, detection, or counting for scientific, general research or laboratory use; electronic analyzers for genetic mutation for scientific, research or laboratory use; particle counters, namely, flow cytometers and image analyzers for scientific, research or laboratory use; genetic testing apparatus and instruments for scientific, research or laboratory use, namely, computer software for scientific analysis of genetic sequences, and laboratory devices for detecting gene mutation; gene amplification analyzers for scientific, research or laboratory use, namely, flow cytometers and image analyzers; oncology analyzers for scientific, research or laboratory use for detecting gene mutations; biological sample pretreatment apparatus and instruments for scientific, research or laboratory use; measurement sample preparation apparatus and instruments for scientific, research or laboratory use; pretreatment apparatus and instruments for genetic testing for laboratory use; testing instruments for genetic testing for detecting gene mutations, namely, Thermal Cycler and Flow cytometer; laboratory instruments for extracting nucleic acid in a biological sample for scientific, research or laboratory use; microplates for laboratory experiment; test tubes for scientific, research or laboratory use; pipette tips for scientific, research or laboratory use; computers. computer programs for controlling apparatus and instruments for use in the field of scientific or laboratory analysis; computer program for controlling apparatus and instruments for use in the field of medical, clinical or diagnostic analysis; and downloadable electronic publications in the nature of magazines and manuals in the field of genetic testing | ACTIVE | — |
| 010 | Medical and veterinary apparatus and instruments for use in sample analysis procedures; apparatus for use in medical analysis, namely, apparatus for detecting gene mutation, namely, Thermal Cycler and Flow cytometer; testing apparatus and instruments for medical or clinical use for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other diagnostic testing; diagnostic apparatus and instruments for medical or clinical use for diagnosing gene mutation; flow cytometers for medical or clinical diagnostic use; flow-based particle analyzers providing cell and particle analysis, detection, or counting for medical or clinical use; particle counters, namely, flow cytometers or flow-based analyzers, for medical or clinical use; genetic testing apparatus and instruments for medical or clinical diagnostic use, namely, apparatus for medical diagnostic testing in the fields of oncology; gene amplification analyzers for detecting gene mutation for medical or clinical use; oncology analyzers for detecting gene mutation for medical or clinical use; biological sample pretreatment apparatus and instruments for medical or clinical use; measurement sample preparation apparatus and instruments for medical or clinical use; pretreatment apparatus and instruments for genetic testing, namely, blood or tissue pretreatment apparatus and instruments for medical use; dropping pipettes for use in medical analysis; measuring apparatus and instruments for use in medical analysis for detecting gene mutation; medical containers especially adapted and designed for use with samples for in vitro diagnosis sold empty; medical sampling bottles especially designed for use in medical analysis, namely, blood sampling tubes. medical devices, namely, disposable beakers especially designed for use in medical analysis, namely, blood or tissue analysis, not for laboratory use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Sysmex Corporation
- Other trademarks owned by Sysmex Corporation
- Other trademarks owned by Sysmex Corporation
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named ONCOBEAM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 13, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Apr 13, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 10, 2021 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Jan 14, 2021 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Jan 14, 2021 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Aug 6, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 5, 2020 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Aug 5, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 9, 2020 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jul 9, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 14, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 10, 2020 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jan 10, 2020 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jan 10, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 8, 2019 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Sep 25, 2019 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jul 4, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 2, 2019 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jul 2, 2019 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jul 2, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 17, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 15, 2019 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 15, 2019 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 15, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 10, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 8, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 8, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 8, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 13, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 19, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 19, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 29, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 11, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 25, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 25, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 24, 2017 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Sep 21, 2017 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Sep 21, 2017 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Sep 21, 2017 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Sep 20, 2017 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Mar 17, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 17, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 17, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 1, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 1, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 1, 2017 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Sep 1, 2016 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Sep 1, 2016 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Sep 1, 2016 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Aug 31, 2016 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Feb 25, 2016 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 25, 2016 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 25, 2016 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 4, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 4, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 1, 2016 | ALIE | ASSIGNED TO LIE | — |
| Jan 22, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 22, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 22, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 22, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 10, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 16, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 16, 2015 | NWAP | NEW APPLICATION ENTERED | — |